obesity-995x60.png
FEATURED ARTICLES
How Plain Language Summaries Created Under EU CTR Can Help Shape NIH Policy
As the NIH shapes its plain language summary policy, EU CTR experience offers practical lessons on clarity, privacy, consistency, and implementation.
-
![Communication icon-GettyImages-1074199622]( "Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D?")
Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D?Integrated technology platforms can connect R&D data, accelerate trials, strengthen quality, and cut costs — but successful adoption requires more than AI.
-
![Solubility And Improved Patient Outcomes-GettyImages-2277363545]( "\"How I Feel\" – The Critical Role Of The Patient Perspective And How To Collect It")
"How I Feel" – The Critical Role Of The Patient Perspective And How To Collect ItNot sure how to capture what patients really experience? Explore five research methods, their strengths and limitations, and how early patient insight can sharpen trial design and development decisions.
-
![two same digital person-GettyImages-964835390]( "How Digital Twins Are Reshaping Clinical R&D")
How Digital Twins Are Reshaping Clinical R&DDiscover how digital twins are helping predict outcomes, streamline recruitment, reduce patient burden, and accelerate clinical development.
SERVICES AND PRODUCTS
Explore the breadth of Altasciences’ expertise in clinical pharmacology studies, supporting regulatory submissions across a diverse range of therapeutic areas.
Managing clinical trial disclosure can be challenging with the ever-evolving regulatory landscape, and varying requirements across different jurisdictions and regulatory bodies. New and updated regulations need to be continuously monitored and assessed for potential impact on an organization, processes and overall strategy.
Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.
DECODE, the Digital Endpoint Collaboration for Outcomes Development, is Ametris’ pre-competitive collaboration framework designed to help address shared clinical measurement challenges across the life sciences industry. In regulatory contexts where evidence expectations are high, digital measures must be meaningful to patients, scientifically valid, operationally feasible, and aligned with regulatory expectations. By supporting the development and validation of fit-for-purpose, patient-centered digital measures, DECODE helps transform real-world data into validated clinical evidence across clinical research programs.